Entity Details

Primary name MYH7_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP12883
EntryNameMYH7_HUMAN
FullNameMyosin-7
TaxID9606
Evidenceevidence at protein level
Length1935
SequenceStatuscomplete
DateCreated1989-10-01
DateModified2021-06-02

Ontological Relatives

GenesMYH7

GO terms

Show/Hide Table
GOName
GO:0000146 microfilament motor activity
GO:0001725 stress fiber
GO:0002026 regulation of the force of heart contraction
GO:0002027 regulation of heart rate
GO:0003009 skeletal muscle contraction
GO:0005516 calmodulin binding
GO:0005524 ATP binding
GO:0005859 muscle myosin complex
GO:0006936 muscle contraction
GO:0006941 striated muscle contraction
GO:0007512 adult heart development
GO:0014728 regulation of the force of skeletal muscle contraction
GO:0014883 transition between fast and slow fiber
GO:0014898 cardiac muscle hypertrophy in response to stress
GO:0016459 myosin complex
GO:0016887 ATP hydrolysis activity
GO:0030016 myofibril
GO:0030017 sarcomere
GO:0030018 Z disc
GO:0030049 muscle filament sliding
GO:0031449 regulation of slow-twitch skeletal muscle fiber contraction
GO:0032982 myosin filament
GO:0046034 ATP metabolic process
GO:0051015 actin filament binding
GO:0055010 ventricular cardiac muscle tissue morphogenesis
GO:0060048 cardiac muscle contraction

Subcellular Location

Show/Hide Table
Subcellular Location
Cytoplasm

Domains

Show/Hide Table
DomainNameCategoryType
IPR000048 IQ motif, EF-hand binding siteSiteBinding site
IPR001609 Myosin head, motor domainDomainDomain
IPR002928 Myosin tailDomainDomain
IPR004009 Myosin, N-terminal, SH3-likeDomainDomain
IPR008989 Myosin S1 fragment, N-terminalFamilyHomologous superfamily
IPR027417 P-loop containing nucleoside triphosphate hydrolaseFamilyHomologous superfamily
IPR036961 Kinesin motor domain superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
192600 OMIMCardiomyopathy, familial hypertrophic 1 (CMH1)A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. The disease is caused by variants affecting the gene represented in this entry.
608358 OMIMMyopathy, myosin storage, autosomal dominant (MSMA)A rare congenital myopathy characterized by subsarcolemmal hyalinized bodies in type 1 muscle fibers. The disease is caused by variants affecting the gene represented in this entry.
160500 OMIMMyopathy, distal, 1 (MPD1)A muscular disorder characterized by early-onset selective weakness of the great toe and ankle dorsiflexors, followed by weakness of the finger extensors. Mild proximal weakness occasionally develops years later after the onset of the disease. The disease is caused by variants affecting the gene represented in this entry.
181430 OMIMScapuloperoneal myopathy MYH7-related (SPMM)Progressive muscular atrophia beginning in the lower legs and affecting the shoulder region earlier and more severely than distal arm. The disease is caused by variants affecting the gene represented in this entry.
613426 OMIMCardiomyopathy, dilated 1S (CMD1S)A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. The disease is caused by variants affecting the gene represented in this entry.
613426 OMIMCardiomyopathy, dilated 1S (CMD1S)A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. The disease is caused by variants affecting distinct genetic loci, including the gene represented in this entry.
255160 OMIMMyopathy, myosin storage, autosomal recessive (MSMB)An autosomal recessive form of myosin storage myopathy, a muscle disease characterized by subsarcolemmal accumulation of hyalinized bodies in type 1 muscle fibers. MSMB clinical features include muscle weakness, type II respiratory failure and cardiac failure, due to hypertrophic cardiomyopathy. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB08378 4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACIDDrugbanksmall molecule